Bendigo Health

bendigohealth.org.au

With more than 3500 staff and covering an area a quarter of the size of Victoria, Bendigo Health Care Group (commonly known as Bendigo Health) is an expanding regional health service offering the advantages of city life combined with the beauty and freedom that comes from living in a regional area. Bendigo Health, around 665 bed service*, treated almost 42,000 inpatients, triaged more than 50,000 emergency attendees and welcomed more than 1,400 new born babies in the reporting period July 1, 2015 to June 30, 2016.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

TETRASCIENCE R&D DATA CLOUD SELECTED BY LEADING CLINICAL-STAGE BIOTECHNOLOGY COMPANY

TetraScience | September 03, 2021

news image

TetraScience, the R&D Data Cloud company, announced today that Zymeworks Inc. has selected the Tetra Data Platform (TDP) to standardize and automate scientific data flow. As a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics, Zymeworks' R&D engine generates and analyzes large amounts of scientific data in its quest to revolutionize drug design. "In order to take advantage of innovative data sc...

Read More

Diagnostics

EXOTHERA ANNOUNCES INDUSTRIAL SCALE AAV MANUFACTURING COLLABORATION WITH LOGICBIO THERAPEUTICS AND POLYPLUS

Exothera | June 15, 2022

news image

Exothera SA today announced a collaboration with LogicBio® Therapeutics and Polyplus-transfection® SA. for the development of a highly scalable AAV manufacturing platform with a capacity from 200 L to 2,000 L. Adeno-associated viruses (AAV) are non-enveloped, non-pathogenic viruses largely used as drug delivery vectors for biotherapeutics, like gene therapies and vaccines. Although the application of AAV is spreading rapidly, the industry is struggling to find cost-effecti...

Read More

Cell and Gene Therapy

Q² SOLUTIONS LAUNCHES INNOVATIVE SELF-COLLECTION SAFETY LAB PANEL IN COLLABORATION WITH TASSO

Q² Solutions and IQVIA, Tasso | October 07, 2022

news image

Q² Solutions, a wholly owned subsidiary of IQVIA and a leading global clinical trial laboratory services organization, today announced the launch of the first self-collection safety lab panel for U.S. clinical trial participants by a leading global clinical trial laboratory. Developed in collaboration with Tasso Inc, a leader in clinical-grade blood collection solutions, this unique offering combines industry leading laboratory services, patient focused logistics and cutting-...

Read More

Medical

NORDIC BIOSCIENCE AND ROCHE DIAGNOSTICS STRENGTHEN COLLABORATION FOR DEVELOPMENT OF BIOMARKERS FOR CHRONIC DISEASES

Nordic Bioscience | June 17, 2022

news image

Nordic Bioscience, a growing biomarker company, today announced the strengthening of its ongoing collaboration with Roche Diagnostics for the development of proprietary biomarkers involved in tissue breakdown and build-up. Nordic Bioscience is a world leader in Extra Cellular Matrix (ECM) biomarker development that can provide fast and objective decision-making for compound selection and development in clinical trials as well as provide value for patients in a diagnostic setting.<...

Read More
news image

Research

TETRASCIENCE R&D DATA CLOUD SELECTED BY LEADING CLINICAL-STAGE BIOTECHNOLOGY COMPANY

TetraScience | September 03, 2021

TetraScience, the R&D Data Cloud company, announced today that Zymeworks Inc. has selected the Tetra Data Platform (TDP) to standardize and automate scientific data flow. As a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics, Zymeworks' R&D engine generates and analyzes large amounts of scientific data in its quest to revolutionize drug design. "In order to take advantage of innovative data sc...

Read More
news image

Diagnostics

EXOTHERA ANNOUNCES INDUSTRIAL SCALE AAV MANUFACTURING COLLABORATION WITH LOGICBIO THERAPEUTICS AND POLYPLUS

Exothera | June 15, 2022

Exothera SA today announced a collaboration with LogicBio® Therapeutics and Polyplus-transfection® SA. for the development of a highly scalable AAV manufacturing platform with a capacity from 200 L to 2,000 L. Adeno-associated viruses (AAV) are non-enveloped, non-pathogenic viruses largely used as drug delivery vectors for biotherapeutics, like gene therapies and vaccines. Although the application of AAV is spreading rapidly, the industry is struggling to find cost-effecti...

Read More
news image

Cell and Gene Therapy

Q² SOLUTIONS LAUNCHES INNOVATIVE SELF-COLLECTION SAFETY LAB PANEL IN COLLABORATION WITH TASSO

Q&amp;#178; Solutions and IQVIA, Tasso | October 07, 2022

Q² Solutions, a wholly owned subsidiary of IQVIA and a leading global clinical trial laboratory services organization, today announced the launch of the first self-collection safety lab panel for U.S. clinical trial participants by a leading global clinical trial laboratory. Developed in collaboration with Tasso Inc, a leader in clinical-grade blood collection solutions, this unique offering combines industry leading laboratory services, patient focused logistics and cutting-...

Read More
news image

Medical

NORDIC BIOSCIENCE AND ROCHE DIAGNOSTICS STRENGTHEN COLLABORATION FOR DEVELOPMENT OF BIOMARKERS FOR CHRONIC DISEASES

Nordic Bioscience | June 17, 2022

Nordic Bioscience, a growing biomarker company, today announced the strengthening of its ongoing collaboration with Roche Diagnostics for the development of proprietary biomarkers involved in tissue breakdown and build-up. Nordic Bioscience is a world leader in Extra Cellular Matrix (ECM) biomarker development that can provide fast and objective decision-making for compound selection and development in clinical trials as well as provide value for patients in a diagnostic setting.<...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us